Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 12/20 | 0.65 |
| ▸ | RAB9A | P51151 | 12/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.65 |
| ▸ | MAPT | P10636 | 11/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 10/20 | 0.65 |
| ▸ | HPGD | P15428 | 9/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.65 |
| ▸ | MEN1 | O00255 | 8/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.65 |
| ▸ | HTT | P42858 | 6/20 | 0.65 |
| ▸ | LMNA | P02545 | 5/20 | 0.65 |
| ▸ | GAA | P10253 | 5/20 | 0.65 |
| ▸ | PKM | P14618 | 3/20 | 0.65 |
| ▸ | GLA | P06280 | 3/20 | 0.65 |
| ▸ | ALPL | P05186 | 1/20 | 0.65 |
| ▸ | ALPG | P10696 | 1/20 | 0.65 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.58 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.58 |
| ▸ | RELA | Q04206 | 2/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL704507 | 0.80 | RAB9A (0.62) | NPC1RAB9AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL704508 | 0.80 | RAB9A (0.62) | NPC1RAB9AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL7808579 | 0.79 | NPC1 (1.00) | NPC1RAB9AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL1086985 | 0.77 | ALDH1A1 (0.81) | NPC1RAB9AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL29539476 | 0.77 | ALDH1A1 (0.81) | NPC1RAB9AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL1086983 | 0.77 | ALDH1A1 (0.81) | NPC1RAB9AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL537590 | 0.77 | MAPT (0.39) | NPC1RAB9AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL537589 | 0.77 | RAB9A (0.41) | NPC1RAB9AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL6481418 | 0.77 | NPC1 (0.76) | NPC1RAB9AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL6479916 | 0.77 | RAB9A (0.61) | NPC1RAB9AALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240066023-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2024-02-29 | — | — | US | disclosed |
| US-11786520-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIV ANA G MENDEZ INC (US) | 2023-10-17 | — | — | US | disclosed |
| US-11311531-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIV ANA G MENDEZ INC (US) | 2022-04-26 | — | — | US | disclosed |
| US-20210290615-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2021-09-23 | — | — | US | disclosed |
| US-20200261441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2020-08-20 | — | — | US | disclosed |
| US-20200246328-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2020-08-06 | — | — | US | disclosed |
| US-10624885-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIV ANA G MENDEZ INC (US) | 2020-04-21 | — | — | US | disclosed |
| US-20180214441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2018-08-02 | — | — | US | disclosed |
| US-9889128-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | Sistema Universitario Ana G. Mendez (PR) | 2018-02-13 | — | — | US | disclosed |
| US-20180008590-A9 | METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2018-01-11 | — | — | US | disclosed |
| US-20170079973-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2017-03-23 | — | — | US | disclosed |
| WO-2016044636-A2 | METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2016-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786520-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | NPC1 1719/4885RAB9A 2184/4885ALDH1A1 2342/4885 |
| US-11311531-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | NPC1 1601/4885RAB9A 2036/4885ALDH1A1 2214/4885 |
| US-20200246328-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | NPC1 1601/4885RAB9A 2036/4885ALDH1A1 2214/4885 |
| US-10624885-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | NPC1 1601/4885RAB9A 2036/4885ALDH1A1 2214/4885 |
| US-20180008590-A9 | METHOD FOR PRODUCING BENZAZOLOQUINOLIUM (BQS) SALTS AND USING THE BIOLOGICAL ACTIVITY OF THE COMPOSITION | RECQL, AHNAK, NDUFS1 | NPC1 1601/4885RAB9A 2036/4885ALDH1A1 2214/4885 |
| US-20210290615-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | NPC1 1719/4885RAB9A 2184/4885ALDH1A1 2342/4885 |
| US-20180214441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | NPC1 1601/4885RAB9A 2036/4885ALDH1A1 2214/4885 |
| US-20240066023-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | NPC1 1719/4885RAB9A 2184/4885ALDH1A1 2342/4885 |
| US-20200261441-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | NPC1 1601/4885RAB9A 2036/4885ALDH1A1 2214/4885 |
| US-20170079973-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | NPC1 1601/4885RAB9A 2036/4885ALDH1A1 2214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.